Fulvestrant vs exemestane for treatment of metastatic breast cancer in patients with acquired resistance to non-steroidal aromatase inhibitors -- a meta-analysis of EFECT and SoFEA (CRUKE/03/021 & CRUK/09/007). - Johnston, S. R. D.; Chia, S.; Kilburn, L. S.; Gradishar, W. J.; Cameron, D.; Dodwell, D.; Ellis, P.; Howell, A.; Im, Y.-H.; Coombes, G.; Piccart, M.; Dowsett, M.; et al. (Cancer Research, 2012)